Investigating the Use of Fluorescence Imaging in Endometrial Cancer Surgery

Completed · Not applicable

Conditions studied: Endometrial Cancer

In brief

The main purpose of the study is to evaluate the detection rate and accuracy of fluorescence imaging in endometrial cancer staging by sentinel node assessment.

Key facts

Study ID

NCT01562106

Run by

Swedish Medical Center

People needed

123

Starts

2012-02-01

Expected to finish

2016-08-01

Last updated by the study team

2016-11-18

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Biopsy proven endometrial carcinoma
• Must have planned to undergo standard endometrial cancer staging surgery as part of their routine clinical care
• Must be 18 years of age and older
• Must be able to comply with all the study procedures

You may not qualify if…

• Significant liver disease, cirrhosis or liver insufficiency with abnormal liver function tests, with total bilirubin > 1.5 times normal, and/or SGOT > 2 times normal
• Uremia, serum creatinine > 2.0 mg/dl
• Previous history of adverse reaction or allergy to ICG dye, iodine, shellfish, or iodine dyes
• Previous lymphadenectomy or surgery that could change the uterine lymphatic drainage
• Pregnant
• Currently participating in a drug, biologic and/or device treatment study
• Any medical condition that would normally prevent someone from receiving general anesthesia or undergoing standard surgical procedures

Where it is running

• Swedish Medical Center Issaquah Campus — Issaquah, Washington, United States
• Pacific Gynecology Specialists — Seattle, Washington, United States
• Swedish Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.